EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
63 hedge funds and large institutions have $215M invested in Eiger BioPharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-5
Holders Change %
-7.35%
% of All Funds
1.37%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
10
Increased
18
Reduced
18
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Millennium Management
New York
|
$2.97M |
2 |
EP
Eversept Partners
New York
|
$975K |
3 |
LCM
Laurion Capital Management
New York
|
$1.59M |
4 |
BC
Broadfin Capital
New York
|
$2.7M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$10.8M |